Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "U.S. Blood Collection Market Size, Share & Trends Analysis Report By Site (Venous, Capillary), By Application (Diagnostics, Treatment), By End Use, By Age, By Demography, By States, And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering.
The U.S. blood collection market size is expected to reach USD 2.08 billion by 2030 and is projected to grow at a CAGR of 8.7% from 2024 to 2030
The increasing prevalence of chronic and infectious diseases, growing number of blood transfusions, and rising prevalence of hematological disorders are primarily driving the overall market growth. As per CDC data, approximately 38 million adults were suffering from diabetes in 2022. In addition, obesity is linked to up to 53% of new type 2 diabetes cases annually. Thus, the increasing prevalence of diabetes is expected to boost the demand for vacutainers in recurring diagnostic tests, such as blood sugar assays. 
The growing prevalence of hematological disorders highlights the need for vacutainers to diagnose these disorders, driving the demand for vacuum blood collection devices. For instance, the Leukemia & Lymphoma Society reports that approximately one person is diagnosed with blood cancer every 3 minutes. This increasing burden of hematological disorders necessitates effective blood collection methods for diagnosis and monitoring, thereby propelling the blood collection market.
The growing advancements in technology have made the blood collection market more sophisticated and accurate. Moreover, expansion of Point-of-Care Testing (POCT) solutions in various healthcare settings, including pharmacies, urgent care centers, and clinics, can drive the demand for blood collection in the U.S.
Community pharmacies are increasingly playing a pivotal role in collection services, leveraging their accessibility and patient trust to enhance healthcare delivery. Thus, community pharmacies are expanding their role in POCT, offering convenient and accessible diagnostic services, including blood collection, directly to patients in the U.S.
U.S. Blood Collection Market Report Highlights
- Based on site, the venous segment dominated the market with a revenue share of 82.3%. owing to its reliability and efficiency in obtaining high-quality samples.
- Based on application, the diagnostics segment dominated the market with a revenue share of 64.1% as it facilitates the accurate assessment and management of various medical conditions.
- Based on end use, the hospitals segment dominated the market with a revenue share of 28.3%, owing to the high number of cases and diagnostic tests being conducted.
- Based on age, the 19 to 65 segment dominated the market with a revenue share of 61.5% due to large numbers of collection procedures being performed on this age group.
- Based on demography, the urban segment dominated the market by contributing 84.8% owing to the presence of well-established hospital infrastructure and a large number of diagnostic laboratories in the U.S.
- Some of the major players operating in this space are Sekisui Medical Co., Ltd., Becton, Dickinson, and Company (BD), Greiner Bio-One, QIAGEN, and Terumo Corporation.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 90 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $1.18 Billion |
| Forecasted Market Value (USD) by 2030 | $2.08 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | United States |
Market Dynamics
Market Driver Analysis
- Increasing Prevalence of Chronic and Infectious Diseases
- Growing Number of Blood Transfusions
- Rising Prevalence of Hematological Disorders
Market Restraint Analysis
- Risks Associated with Blood Collection
- Stringent Regulations on Blood Collection
U.S. Blood Collection Market Analysis Tools
- Industry Analysis - Porter's
- PESTEL Analysis
- Regulatory Framework
- Pricing Analysis
- Estimated Animal Population, by key countries & Key species, 2023
- COVID-19 Impact Analysis
Competitive Landscape
- Sekisui Medical Co., Ltd.
- Becton, Dickinson and Company (BD)
- Greiner Bio-One
- QIAGEN
- Nipro Corporation
- Terumo Corporation
- Haemonetics Corp.
- Zhejiang Gongdong Medical Technology Co., Ltd
- Drucker Diagnostics
- AdvaCare Pharma
For more information about this report visit https://www.researchandmarkets.com/r/a8v6cq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
